Literature DB >> 6345586

Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes.

A Durandy, A Fischer, C Griscelli.   

Abstract

We have developed a new antigenic system for the induction of specific in vitro antibody response in man. The antigen used was purified from the cell wall of Candida albicans strain A and contained greater than 96% polysaccharide mannan. Peripheral blood mononuclear cells from Candida-sensitized donors produced specific antimannan antibodies during a 7-d culture in the presence of mannan absorbed with methylated bovine serum albumin. Two methods were used to detect antimannan antibody responses. Antimannan antibody-producing cells were identified by radioautography with tritiated mannan. Antibody concentration in culture supernatants was measured by an enzyme-linked immunosorbent assay. In both methods, specific IgM and IgG (but not IgA) antibodies were detected. The antibody production to mannan was specific, since an antigenically unrelated polysaccharide (pneumococcal antigen S III) did not bind to methylated bovine serum albumin-mannan-induced blast cells and did not induce antimannan antibody-containing cells. Furthermore, a pulse with an excess of unlabeled mannan abolished [3H]mannan binding, whereas an excess of unlabeled S III did not. Similarly, no antimannan antibody was obtained in influenza virus-stimulated cultures and mannan-stimulated cultures were not inducing antiinfluenza antibodies. The antimannan antibody production was shown to be a T cell-dependent phenomenon. The T helper effect appeared to be radiosensitive. It was under a genetic restriction as it occurred only in autologous or semi-identical but not in allogeneic situations. This system is relatively simple, reproducible, and well suited for the study of specific secondary in vitro antibody responses to polysaccharide antigens in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345586      PMCID: PMC370366          DOI: 10.1172/jci110916

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

Review 1.  Mechanisms of b cell triggering: studies with t cell-independent antigens.

Authors:  G G Klaus; J H Humphrey
Journal:  Transplant Rev       Date:  1975

Review 2.  Analysis of human Candida precipitins by quantitative immunoelectrophoresis: a model for analysis of complex microbial antigen-antibody systems.

Authors:  N H Axelsen
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

3.  Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.

Authors:  P H Baker; P W Stashak
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

4.  The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition.

Authors:  R M Blaese; W Strober; R S Brown; T A Waldmann
Journal:  Lancet       Date:  1968-05-18       Impact factor: 79.321

Review 5.  Cell selection by antigen in the immune response.

Authors:  G W Siskind; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

6.  Simultaneous characterization of free Candida antigens and Candida precipitins in a patient's serum by means of crossed immunoelectrophoresis with intermidiate gel.

Authors:  N H Axelsen; C H Kirkpatrick
Journal:  J Immunol Methods       Date:  1973-04       Impact factor: 2.303

7.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

8.  Differences in antigen handling by peritoneal macrophages from the Biozzi high and low responder lines of mice.

Authors:  E Wiener; A Bandieri
Journal:  Eur J Immunol       Date:  1974-07       Impact factor: 5.532

9.  Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes.

Authors:  A S Fauci; K R Pratt
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

10.  Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes.

Authors:  R S Geha; E Schneeberger; F S Rosen; E Merler
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  5 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Activation of genetically major histocompatibility complex (MHC) class II-deficient B lymphocytes.

Authors:  A Durandy; M Mangeney; C Griscelli; M Forveille; F Le Deist; A Fischer
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

3.  Specific binding of antigen onto human T lymphocytes.

Authors:  A Durandy; A Fischer; D Charron; C Griscelli
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells.

Authors:  R E Garner; A M Childress; L G Human; J E Domer
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

5.  Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis.

Authors:  A Durandy; A Fischer; F Le Deist; E Drouhet; C Griscelli
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.